Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Rating of “Buy” from Brokerages
Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 […]
Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 […]
